Baxalta to Advance Care for Hemophilia A patients with FDA Approval of ADYNOVATE, a Simple, Twice-weekly Treatment to Reduce Bleeds
 
Baxalta Submits Marketing Authorization Application to the European Medicines Agency for ADYNOVI for Treatment of Hemophilia A Patients
  



News Headlines
Events Calendar
May 3, 2016 Q1 2016 Financial Results Call
4:30 p.m. ET/1:30 p.m. PT
Dial in: (877) 881-2183 (U.S.);
(970) 315-0453 (international) Passcode: 96031147
Event will be webcast
March 9, 2016 Cowen & Company 36th Annual Healthcare Conference
Presentation - 8:40 a.m. ET
Event will be webcast
Presentation Slides
October 8, 2015 Nektar's Investor and Analyst
R&D Day
12:30 - 3:30 p.m. ET
Event will be webcast
Presentation Slides
Media Highlights
PharmaVoice:
Pharma R&D is Now Biomarker-Driven
Drug Discovery News:
Nektar makes progress against glioma
MIT Technology Review:
Opioids without Addiction
Nektar's Media Site
Broadcast Video
Image Gallery
Follow Us On Twitter
 
Site Map Privacy Terms of Use Trademarks Site Users Guide